Should you buy Hims & Hers stock? (November 2023)

I've started something new: https://www.3minutebreakdowns.com Hims & Hers stock analysis. Ticker: $HIMS This company provides treatments for erectile dysfunction and hair loss and it's one of the fastest growing stocks on the market! Hims and Hers Health provides products through a digital telehealth service. The company grew revenues 83% in 2021, 94% in 2022 and this years revenue should grow 65% to roughly 870 million. Total subscribers grew 56% in the latest quarter to 1.4 million and gross margins have increased to an impressive 81%. Despite such impressive growth, HIMS stock trades at only 2 times revenue and 42 times adjusted EBITDA. That’s extremely cheap for such rapid growth. #himsstock #investing #stockstowatch